HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Muro Selected Research

Pain (Aches)

8/2012Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Muro Research Topics

Disease

7Infections
10/2019 - 05/2005
6Schistosomiasis (Bilharziasis)
10/2019 - 11/2004
2Malaria
01/2017 - 01/2015
1Hypersensitivity (Allergy)
08/2012
1Neuralgia (Stump Neuralgia)
08/2012
1Pain (Aches)
08/2012
1Filariasis
05/2011
1Reinfection
06/2007
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
05/2004
1Eosinophilia
05/2004
1Fascioliasis
06/2001

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
01/2017 - 06/2007
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 11/2006
2Fatty Acid-Binding ProteinsIBA
05/2008 - 06/2001
214-3-3 Proteins (14-3-3 Protein)IBA
10/2007 - 06/2007
2EnzymesIBA
05/2005 - 11/2004
2ImmunosorbentsIBA
05/2005 - 11/2004
2AntigensIBA
05/2005 - 11/2004
1Proteins (Proteins, Gene)FDA Link
01/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2012
1LigandsIBA
08/2012
1Sigma-1 ReceptorIBA
08/2012
1Capsaicin (Zostrix)FDA Link
08/2012
1Formaldehyde (Formol)FDA Link
08/2012
1Molecular Chaperones (Chaperone, Molecular)IBA
08/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2011
1EndostatinsIBA
05/2011
1AntibodiesIBA
11/2004

Therapy/Procedure

1Therapeutics
05/2004